Sinoway Industrial Co., Ltd.

Celecoxib 169590-42-5 Celecoxib 169590-42-5

Celecoxib 169590-42-5
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Celecoxib:

Name

Celecoxib

CAS NO.

169590-42-5

Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.38

Grade Standard

Medicine grade  / 99% min / USP/ EP / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Celecoxib: 

Celecoxib is used to relieve the symptoms and signs of osteoarthritis, relieve the symptoms and signs of rheumatoid arthritis, and treat acute pain in adults.

The highest blood concentration was achieved approximately 3 hours after oral administration of a single dose of celecoxib. In the fasting state, when the dose of celecoxib is as high as 200mg twice daily, the highest blood concentration (Cmax) and the area under the curve (AUC) are roughly proportional to the dose; when the dose is increased, this proportional relationship Weaken (see food effects). At present, no studies have been conducted on absolute bioavailability. Steady-state plasma levels can be reached within 5 days after multiple doses.

COA of Celecoxib :


COA of Celecoxib

* Products under the patent are only for R&D use.

  • Hydrocortisone Acetate 50-03-3
    Basic informationProduct Name: Hydrocortisone AcetateMolecular Formula : C23H32O6Molecular Weight: 404.5CAS No.: 50-03-3Appearance: White crystalline powderSpecifications:EP8; EP6/USP37UsagesEczema, itchy... Hydrocortisone Acetate 50-03-3
  • Fusidic Acid 6990-06-3
    Basic information of Fusidic AcidNameFusidic Acid AliasFusidate sodium; Diethanolamine fusidate; FUCIDIN; fusdic acid; (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,... Fusidic Acid 6990-06-3
  • Eptifibatide 188627-80-7
    Basic information of Eptifibatide:NameEptifibatideCAS NO.188627-80-7Molecular Formula C35H49N11O9S2Molecular Weight 831.96Grade StandardMedicine grade / 99% min / FDA / DMFPackage Size1kg/bag; 5kg/... Eptifibatide 188627-80-7
  • Ganciclovir 82410-32-0
    Basic InformationProduct Name: Ganciclovir Synonym: GancyclovirCas No.: 82410-32-0Molecular Formula: C9H13N5O4Molecular Weight: 255.23 Specification: USPUsage: Ganciclovir is an antiviral. It is use... Ganciclovir 82410-32-0

MORE_DETAIL Celecoxib 169590-42-5

Basic information of Celecoxib:

Name

Celecoxib

CAS NO.

169590-42-5

Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.38

Grade Standard

Medicine grade  / 99% min / USP/ EP / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Celecoxib: 

Celecoxib is used to relieve the symptoms and signs of osteoarthritis, relieve the symptoms and signs of rheumatoid arthritis, and treat acute pain in adults.

The highest blood concentration was achieved approximately 3 hours after oral administration of a single dose of celecoxib. In the fasting state, when the dose of celecoxib is as high as 200mg twice daily, the highest blood concentration (Cmax) and the area under the curve (AUC) are roughly proportional to the dose; when the dose is increased, this proportional relationship Weaken (see food effects). At present, no studies have been conducted on absolute bioavailability. Steady-state plasma levels can be reached within 5 days after multiple doses.

COA of Celecoxib :


COA of Celecoxib

* Products under the patent are only for R&D use.
Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//